Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Landscape and the immune patterns of cuproptosis in oral squamous cell carcinoma. | J Oral Pathol Med | 2023 | 37828627 | PubTator, text mining | PubMed |
| DLAT is a promising prognostic marker and therapeutic target for hepatocellular carcinoma: a comprehensive study based on public databases. | Sci Rep | 2023 | 37828099 | PubTator, text mining | PubMed |
| Multi-omics analysis of MRPL-13 as a tumor-promoting marker from pan-cancer to lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37827692 | PubTator, text mining | PubMed |
| The role of novel programmed cell death in head and neck squamous cell carcinoma: from mechanisms to potential therapies. | Front Pharmacol | 2023 | 37818196 | PubTator, text mining | PubMed |
| Prognostic value and immune landscapes of cuproptosis-related lncRNAs in esophageal squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37812189 | PubTator, text mining | PubMed |
| A Novel Variant in the Desmoplakin Gene in One Case of the Rare Carvajal Syndrome with Dilated Cardiomyopathy: A Case Report and Literature Review. | Clin Cosmet Investig Dermatol | 2023 | 37799505 | PubTator, text mining | PubMed |
| Genetic diversity, tissue-specific expression, and functional analysis of the ATP7A gene in sheep. | Front Genet | 2023 | 37799137 | PubTator, text mining | PubMed |
| Bioinformatics analysis of copper death gene in diabetic immune infiltration. | Medicine (Baltimore) | 2023 | 37773841 | PubTator, text mining | PubMed |
| Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies. | Front Pharmacol | 2023 | 37767404 | PubTator, text mining | PubMed |
VNLG-152R and its deuterated analogs potently inhibit/repress triple/quadruple negative breast cancer of diverse racial origins in vitro and in vivo by upregulating E3 Ligase Synoviolin 1 (SYVN1) and inducing proteasomal degradation of MNK1/2. | Front Oncol | 2023 | 37766871 | PubTator, text mining | PubMed |
| Elucidating Cuproptosis-Associated Genes in the Progression from Nash to HCC Using Bulk and Single-Cell RNA Sequencing Analyses and Experimental Validation. | Medicina (Kaunas) | 2023 | 37763758 | PubTator, text mining | PubMed |
| In Silico Analysis Reveals the Modulation of Ion Transmembrane Transporters in the Cerebellum of Alzheimer's Disease Patients. | Int J Mol Sci | 2023 | 37762226 | PubTator, text mining | PubMed |
| Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson's Phenotype Development. | Antioxidants (Basel) | 2023 | 37759957 | PubTator, text mining | PubMed |
| Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis. | Eur Respir Rev | 2023 | 37758276 | PubTator, text mining | PubMed |
| [Construction of Lung Adenocarcinoma Prognosis Model and Drug Sensitivity Analysis Based on Cuproptosis Related Genes]. | Zhongguo Fei Ai Za Zhi | 2023 | 37752539 | PubTator, text mining | PubMed |
| α-lipoic acid ameliorates consequences of copper overload by up-regulating selenoproteins and decreasing redox misbalance. | Proc Natl Acad Sci U S A | 2023 | 37751556 | PubTator, text mining | PubMed |
| Prediction of prognosis, immune infiltration, and personalized treatment of hepatocellular carcinoma by analysis of cuproptosis-related long noncoding RNAs and verification in vitro. | Front Oncol | 2023 | 37746284 | PubTator, text mining | PubMed |
| A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma. | Front Pharmacol | 2023 | 37745054 | PubTator, text mining | PubMed |
| Novel insights into anticancer mechanisms of elesclomol: More than a prooxidant drug. | Redox Biol | 2023 | 37734229 | PubTator, text mining | PubMed |
| Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing. | Arthritis Res Ther | 2023 | 37730603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=16